# 3M Company, Saint Paul, MN – FDA Inspections

Source: https://www.keypedia.com/companies/3m-company/2cb29977-0876-46cd-88ee-7c37ec8ca321

> Inspection records and compliance data for 3M Company in Saint Paul, Minnesota. 6 FDA inspections on record, last inspected March 20, 2020.

---

## Details

- Name: 3M Company
- FEI Number: 2126770
- Business Operations: API/FDF ANALYTICAL TESTING, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING
- Address Line 1: 2510 Conway Ave E
- City: Saint Paul
- State: Minnesota
- Zip Code: 55144
- Country Name: United States
- Address: 2510 Conway Ave E, Saint Paul, Minnesota 55144, United States
- Country: United States

## Related Documents

- [FDA Inspection 1123567 - 3M Company - 2020-03-20](https://www.keypedia.com/records/fda_inspections/3m-company/544c3c70-01af-4b48-9d48-3fab9802c765) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 20, 2020
- [FDA Inspection 1075144 - 3M Company - 2018-10-19](https://www.keypedia.com/records/fda_inspections/3m-company/70c88e87-5b99-43ca-8e54-9ce321a2786f) — classification: No Action Indicated (NAI), source: FDA, date: October 19, 2018
- [FDA Inspection 907895 - 3M Company - 2014-12-15](https://www.keypedia.com/records/fda_inspections/3m-company/74996f81-2c3d-440a-819b-40e9f0916ff2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 15, 2014
- FDA Inspection 828412 - 3M Company - 2013-04-18 — classification: No Action Indicated (NAI), source: FDA, date: April 18, 2013
- FDA Inspection 778370 - 3M Company - 2012-04-20 — classification: No Action Indicated (NAI), source: FDA, date: April 20, 2012
- FDA Inspection 634005 - 3M Company - 2009-10-30 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 30, 2009

## Related Companies

- [Nivagen Pharmaceuticals Inc](https://www.keypedia.com/companies/nivagen-pharmaceuticals-inc/3eba9a8d-d560-49ef-956e-aa59eea20360)
- [Biospectra, Inc.](https://www.keypedia.com/companies/biospectra-inc/bb32a74e-c76f-4ea1-b504-bf2a62f1795d)
- [Incog Biopharma Services, Inc.](https://www.keypedia.com/companies/incog-biopharma-services-inc/6e8ec293-9414-4eec-921f-5e0ca40b7b20)
- [Avista Pharma Solutions, Inc. dba Cambrex](https://www.keypedia.com/companies/avista-pharma-solutions-inc-dba-cambrex/56214bca-3cc9-496a-a019-aab43c351824)
- [Shire Human Genetic Therapies, Inc.](https://www.keypedia.com/companies/shire-human-genetic-therapies-inc/1d1f96ea-a020-4019-96a3-aee02e95246e)
- [Liquidia Technologies, Inc.](https://www.keypedia.com/companies/liquidia-technologies-inc/4c70764b-1078-4221-a9a3-804b2e1be087)
- [Avon Cosmetics Manufacturing, S. de R.L. de C.V.](https://www.keypedia.com/companies/avon-cosmetics-manufacturing-s-de-rl-de-cv/0b454282-8607-4500-9fe4-a5c4f42a880c)
- [H. Lundbeck A/S](https://www.keypedia.com/companies/h-lundbeck-as/4b76a8b4-6579-46ed-84ab-5ad99bb036e5)
- [BrightGene Pharmaceutical Co., Ltd.(Jiangyun Road)](https://www.keypedia.com/companies/brightgene-pharmaceutical-co-ltdjiangyun-road/fee25d1b-c470-4be1-8b02-9ffa6e044007)
- [KLM Laboratories Private Limited](https://www.keypedia.com/companies/klm-laboratories-private-limited/0d018fbe-980c-41e7-8054-a2929f055099)